DFE Pharma, a global leader in pharmaceutical excipients, has appointed Peter Rose as Chief Operating Officer, effective 1 September, when he also joined the company’s Leadership Team. He succeeds Teun Heijnen, who will retire at the end of 2026.

Peter brings more than two decades of experience in the pharmaceutical industry, following the start of his career in the dairy sector. His core expertise lies in building and developing operations teams while driving innovation at scale. Most recently, he served as Vice President and Managing Director at LGC, following a long and successful career across various areas of the pharmaceutical industry, where he held senior manufacturing and operations leadership roles and headed complex operations units and greenfield projects.

“Operational excellence is central to how we deliver on our promises to customers,” said Dr. Sven Abend, CEO of DFE Pharma. “Peter’s experience in building strong operations teams, improving performance, and driving practical innovation will help us further strengthen reliability, agility, and customer focus across our organization. His leadership approach is strongly aligned with our value of ‘Better every day’: continuously improving, taking accountability, and delivering meaningful value for customers and, ultimately, patients.”